If you bought Trannies ahead of The FOMC, then you get nothing. The S&P 500 has now alternated down and up for last 9 days. It’s been quite a ride post-FOMC…
On the day, Trannies got trounced by Railroad warnings and Biotechs buggered by Gilead…
Sectors all rolled over hard into today’s close…
Today’s market traded in a very narrow range and on […]
U.S. indexes were generally positive until the closing minutes when some sort of selling program pushed indexes into the red. The S&P 500 fell 0.17% and the NASDAQ 0.32%. News flow was quiet as existing home sales in February were up 1.2%, to an annual rate of 4.88 million units, slightly below expectations.Fun fact: The S&P 500 has gone 24 […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
Benchmarks ended in the green on Friday as weaker dollar and encouraging earnings results from Nike boosted investor sentiment. Weaker dollar had a positive impact on oil prices, which in turn helped energy shares move up. The Nasdaq reached a 15-year high and finished above 5k mark on Friday. Moreover, the S&P 500 registered weekly gains for the first time […]
Stock Trading Alert: Slightly Negative Expectations Following Last Week’s RallyBy: Paul Rejczak | Mon, Mar 23, 2015SharePrintEmailStock Trading Alert originally published on March 23, 2015, 7:18 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook (next 1-3 months): […]
Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]
(AP Photo/Richard Drew)
Thanks to the removal of just one word in a monetary policy statement and a subsequent weakening in the U.S. dollar, the equity markets have rallied over the last two-and-a-half trading sessions — and the sea of green was abundant in market action on Friday. All three indices opened for trading in positive territory and only climbed […]
The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]
Traders work on the floor of the New York Stock Exchange on March 20, 2015. AP Photo/Richard DrewU.S. stocks surged on Friday, lifting the Nasdaq Composite (COMP) to a 15-year high, as Wall Street embraced quarterly results from Nike (NKE) and others and the U.S. dollar softened against other global currencies.”The fact that the Nasdaq is above 5,000 from technical […]
Strengthening U.S. dollar and a slump in oil prices dragged benchmarks lower on Friday. US crude prices dropped to their lowest levels since Jan 28. Meanwhile, declines in producer prices and consumer confidence added to the bearish sentiment. Benchmarks also posted losses for the third straight week, mostly spooked by sooner-than-expected rate hike fears.For a look at the issues currently […]
